Orakl Oncology
Leveraging patient tumor avatars to transform drug development in oncology.
Cancer complexity leads to a 96% failure rate of drug candidates in clinical trials and a shortage of new treatments. Orakl Oncology’s ambition is to finally address the heterogeneity of cancer and patient specificities as early as possible in drug development.
By creating a collection of avatars of patients’ tumors, they predict how each patient will respond to future drugs, combining best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients.
aerska
Pioneering RNA medicines to treat, delay, and prevent diseases of the brain.
BlubBlub
Video modeling and gamified activities to help children improve their speech and language skills.
Charles.co
A digital clinic specializing in men’s health.
Doccla
Building the next-gen virtual ward company.
Fertifa
Enabling companies, large and small, to put DEI and employee well-being into practice.
Five Lives
Building digital tools for the tracking and improvement of cognitive health.
Flinn
Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.
Fuse
Bringing price transparency to US healthcare.
